Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin

Detalhes bibliográficos
Autor(a) principal: Rodrigues, Daniela A
Data de Publicação: 2021
Outros Autores: Miguel, Sónia P, Loureiro, Jorge, Ribeiro, Maximiano, Roque, Fátima, Coutinho, Paula
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10314/7390
https://doi.org/10.3390/pharmaceutics13122030
Resumo: Digoxin is a hydrophobic drug used for the treatment of heart failure that possesses a narrow therapeutic index, which raises safety concerns for toxicity. This is of utmost relevance in specific populations, such as the elderly. This study aimed to demonstrate the potential of the sodium alginate films as buccal drug delivery system containing zein nanoparticles incorporated with digoxin to reduce the number of doses, facilitating the administration with a quick onset of action. The film was prepared using the solvent casting method, whereas nanoparticles by the nanoprecipitation method. The nanoparticles incorporated with digoxin (0.25 mg/mL) exhibited a mean size of 87.20 ± 0.88 nm, a polydispersity index of 0.23 ± 0.00, and a zeta potential of 21.23 ± 0.07 mV. Digoxin was successfully encapsulated into zein nanoparticles with an encapsulation efficiency of 91% (±0.00). Films with/without glycerol and with different concentrations of ethanol were produced. The sodium alginate (SA) films with 10% ethanol demonstrated good performance for swelling (maximum of 1474%) and mechanical properties, with a mean tensile strength of 0.40 ± 0.04 MPa and an elongation at break of 27.85% (±0.58), compatible with drug delivery application into the buccal mucosa. The current study suggests that SA films with digoxin-loaded zein nanoparticles can be an effective alternative to the dosage forms available on the market for digoxin administration.
id RCAP_18604cc7ac7924c95a10d1977d6b55d6
oai_identifier_str oai:bdigital.ipg.pt:10314/7390
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxindigoxinheart failurenanoparticle drug carriersoromucosal filmssodium alginatezeinDigoxin is a hydrophobic drug used for the treatment of heart failure that possesses a narrow therapeutic index, which raises safety concerns for toxicity. This is of utmost relevance in specific populations, such as the elderly. This study aimed to demonstrate the potential of the sodium alginate films as buccal drug delivery system containing zein nanoparticles incorporated with digoxin to reduce the number of doses, facilitating the administration with a quick onset of action. The film was prepared using the solvent casting method, whereas nanoparticles by the nanoprecipitation method. The nanoparticles incorporated with digoxin (0.25 mg/mL) exhibited a mean size of 87.20 ± 0.88 nm, a polydispersity index of 0.23 ± 0.00, and a zeta potential of 21.23 ± 0.07 mV. Digoxin was successfully encapsulated into zein nanoparticles with an encapsulation efficiency of 91% (±0.00). Films with/without glycerol and with different concentrations of ethanol were produced. The sodium alginate (SA) films with 10% ethanol demonstrated good performance for swelling (maximum of 1474%) and mechanical properties, with a mean tensile strength of 0.40 ± 0.04 MPa and an elongation at break of 27.85% (±0.58), compatible with drug delivery application into the buccal mucosa. The current study suggests that SA films with digoxin-loaded zein nanoparticles can be an effective alternative to the dosage forms available on the market for digoxin administration.2023-01-20T17:02:36Z2023-01-202021-11-29T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10314/7390http://hdl.handle.net/10314/7390https://doi.org/10.3390/pharmaceutics13122030eng34959312Rodrigues, Daniela AMiguel, Sónia PLoureiro, JorgeRibeiro, MaximianoRoque, FátimaCoutinho, Paulainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-01-14T02:59:58Zoai:bdigital.ipg.pt:10314/7390Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:44:13.956145Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
title Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
spellingShingle Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
Rodrigues, Daniela A
digoxin
heart failure
nanoparticle drug carriers
oromucosal films
sodium alginate
zein
title_short Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
title_full Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
title_fullStr Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
title_full_unstemmed Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
title_sort Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
author Rodrigues, Daniela A
author_facet Rodrigues, Daniela A
Miguel, Sónia P
Loureiro, Jorge
Ribeiro, Maximiano
Roque, Fátima
Coutinho, Paula
author_role author
author2 Miguel, Sónia P
Loureiro, Jorge
Ribeiro, Maximiano
Roque, Fátima
Coutinho, Paula
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Rodrigues, Daniela A
Miguel, Sónia P
Loureiro, Jorge
Ribeiro, Maximiano
Roque, Fátima
Coutinho, Paula
dc.subject.por.fl_str_mv digoxin
heart failure
nanoparticle drug carriers
oromucosal films
sodium alginate
zein
topic digoxin
heart failure
nanoparticle drug carriers
oromucosal films
sodium alginate
zein
description Digoxin is a hydrophobic drug used for the treatment of heart failure that possesses a narrow therapeutic index, which raises safety concerns for toxicity. This is of utmost relevance in specific populations, such as the elderly. This study aimed to demonstrate the potential of the sodium alginate films as buccal drug delivery system containing zein nanoparticles incorporated with digoxin to reduce the number of doses, facilitating the administration with a quick onset of action. The film was prepared using the solvent casting method, whereas nanoparticles by the nanoprecipitation method. The nanoparticles incorporated with digoxin (0.25 mg/mL) exhibited a mean size of 87.20 ± 0.88 nm, a polydispersity index of 0.23 ± 0.00, and a zeta potential of 21.23 ± 0.07 mV. Digoxin was successfully encapsulated into zein nanoparticles with an encapsulation efficiency of 91% (±0.00). Films with/without glycerol and with different concentrations of ethanol were produced. The sodium alginate (SA) films with 10% ethanol demonstrated good performance for swelling (maximum of 1474%) and mechanical properties, with a mean tensile strength of 0.40 ± 0.04 MPa and an elongation at break of 27.85% (±0.58), compatible with drug delivery application into the buccal mucosa. The current study suggests that SA films with digoxin-loaded zein nanoparticles can be an effective alternative to the dosage forms available on the market for digoxin administration.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-29T00:00:00Z
2023-01-20T17:02:36Z
2023-01-20
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10314/7390
http://hdl.handle.net/10314/7390
https://doi.org/10.3390/pharmaceutics13122030
url http://hdl.handle.net/10314/7390
https://doi.org/10.3390/pharmaceutics13122030
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 34959312
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136937783590912